X-ray price cuts hit Schering's diagnostics sales
This article was originally published in Clinica
Executive Summary
Price cuts in X-ray contrast media in Germany and Japan resulted in a 2% drop in Schering's diagnostics sales in 1997. In constant currencies, this reflects a 5% decline. However, Schering says sales of Magnevist, its top-selling magnetic resonance imaging (MRI) product, rose 10%, contrary to the general trend in this market. This is due in part to co-operation agreements with major purchasing organisations in the US. German company Schering says it has a leading position in the market for X-ray, MRI and ultrasound contrast media.